ENTERO

What Entero Healthcare Solutions promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 26 tracked 9 delivered 3 missed 14 open
  • Long-term Return on Equity (ROE) delivered said Q4 FY24 Promised: 20% plus in 2-3 years Q1 FY27: Q1 FY27 ROE was reported at 20.4%, meeting the original long-term target of '20% plus' well ahead of the previously diluted timeline.
  • FY25 Revenue Growth missed said Q4 FY24 Promised: 35% to 40% revenue growth in FY '25 Q1 FY27: This promise pertains to a past financial year (FY25) and was not addressed.
  • Long-term EBITDA Margin on track said Q4 FY25 Promised: close to 5% beyond FY26 Q1 FY27: Achieved 5.0% EBITDA margin in Q1 FY27, hitting the long-term target in the first quarter beyond FY26. This demonstrates strong progress towards sustaining this level.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 26 tracked commitments for Entero Healthcare Solutions — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens